Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis

Trial Profile

An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2018

At a glance

  • Drugs Mometasone (Primary)
  • Indications Rhinosinusitis
  • Focus Adverse reactions
  • Sponsors Lyra Therapeutics
  • Most Recent Events

    • 08 Oct 2018 According to a Lyra Therapeutics media release, Richard Douglas, M.D. (Professor of Surgery at The University of Auckland, New Zealand), is the lead investigator of this trial.
    • 08 Oct 2018 According to a Lyra Therapeutics media release, data from this trial was presented at the American Rhinologic Society Annual Meeting (Oct 2018).
    • 08 Oct 2018 Results presented in the Lyra Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top